Jeffrey Conroy

Director Ejecutivo en

Embody, Inc.

61 años

33 relaciones

Health Technology

Consumer Services

Commercial Services

Perfil

Jeffrey Conroy is the Chairman & Chief Executive Officer and founder of Embody, Inc. which is founded in 2014.
He is currently an Independent Director at Cingulate Therapeutics LLC, Virginia Biosciences Health Research Corp., and Cingulate Works, Inc. He was formerly the Chairman of Virginia Biotechnology Association from 2014 to 2017.
He was also a Managing Director at Windward Investments LLC from 2012 to 2019 and Adjuvant Partners LLC from 2000 to 2012.
Additionally, he was the Head-Corporate Development at Específicos Stendhal SA de CV from 2012 to 2019.
He holds an undergraduate degree from Providence College.

Cargos activos de Jeffrey Conroy

Empresas	Cargo	Inicio
Cingulate Therapeutics LLC Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products	Director/Miembro de la Junta	31/05/2018
Embody, Inc. Embody, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes implantable medical devices	Director Ejecutivo	01/07/2015
Cingulate Works, Inc. Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders	Director/Miembro de la Junta	01/05/2018
Virginia Biosciences Health Research Corp. Virginia Biosciences Health Research Corp. Virginia Biosciences Health Research Corp., operating as Catalyst, is a nonprofit organization established by the general assembly and funded by the commonwealth and five public research universities. The non-profit company is based in Richmond, VA. The company advances economic development by fostering collaborations between research universities and the life sciences industry to address unmet medical and life science needs, improve human health, and create jobs. Catalyst accelerates translational bioscience research and commercialization through strategic initiatives and provides competitive grant funding to support collaborative projects involving at least two research universities and an industry partner. Funded projects focus on technologies with market potential in areas such as bioinformatics, medical informatics, point-of-care diagnostics, drug discovery, and delivery. Grant applications undergo a multi-step review process, and funding is milestone-based, requiring measurable goals, matching funds, and progress reporting. The company emphasizes strong project management, scientific merit, commercialization plans, and impartial evaluation of grant applications.	Director/Miembro de la Junta	-

Todos los cargos activos de Jeffrey Conroy

Antiguos cargos conocidos de Jeffrey Conroy.

Empresas	Cargo	Fin
CINGULATE INC.	Director/Miembro de la Junta	05/01/2023
ODYSSEY HEALTH, INC.	Director/Miembro de la Junta	04/01/2023
Windward Investments LLC Windward Investments LLC Financial ConglomeratesFinance Functions as an investment holding company	Corporate Officer/Principal	01/12/2019
Específicos Stendhal SA de CV Específicos Stendhal SA de CV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Corporate Officer/Principal	01/01/2019
Virginia Biotechnology Association Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Promotes biotechnology industry	Presidente	30/08/2017

Ver el detalle de la experiencia de Jeffrey Conroy.

Formación de Jeffrey Conroy.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jeffrey Conroy.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	11
Cingulate Therapeutics LLC Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products	Health Technology
Odyssey Health, Inc. Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices	Health Technology
Providence College Providence College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Virginia Biotechnology Association Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Promotes biotechnology industry	Commercial Services
Específicos Stendhal SA de CV Específicos Stendhal SA de CV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Windward Investments LLC Windward Investments LLC Financial ConglomeratesFinance Functions as an investment holding company	Finance
Embody, Inc. Embody, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes implantable medical devices	Health Technology
Adjuvant Partners LLC
Virginia Biosciences Health Research Corp. Virginia Biosciences Health Research Corp. Virginia Biosciences Health Research Corp., operating as Catalyst, is a nonprofit organization established by the general assembly and funded by the commonwealth and five public research universities. The non-profit company is based in Richmond, VA. The company advances economic development by fostering collaborations between research universities and the life sciences industry to address unmet medical and life science needs, improve human health, and create jobs. Catalyst accelerates translational bioscience research and commercialization through strategic initiatives and provides competitive grant funding to support collaborative projects involving at least two research universities and an industry partner. Funded projects focus on technologies with market potential in areas such as bioinformatics, medical informatics, point-of-care diagnostics, drug discovery, and delivery. Grant applications undergo a multi-step review process, and funding is milestone-based, requiring measurable goals, matching funds, and progress reporting. The company emphasizes strong project management, scientific merit, commercialization plans, and impartial evaluation of grant applications.
Cingulate Works, Inc. Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders	Health Technology
Cingulate, Inc. Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology